**Background:** The ventral tegmental area (VTA) is a midbrain region critical for reward, motivation, and aversion, primarily known for its dopaminergic projections. However, the VTA also contains GABAergic and glutamatergic neurons, including a heterogeneous population expressing somatostatin (Sst). Previous work identified three Sst+ neuron subtypes in the VTA (75% GABA, 18% Glu, 5% GABA/Glu) with distinct locations and electrophysiological properties, including local inhibition of dopamine neurons. Given that Sst+ neurons in other subcortical regions (e.g., amygdala, BNST, LH) project to distant areas and modulate behavior, this study investigated whether VTA Sst neurons also send long-range projections and assessed their behavioral roles using a loss-of-function approach.
**Methods:** The study used Sst-IRES-Cre mice crossed with Ai14 tdTomato reporters. For anterograde tracing, a Cre-dependent AAV expressing eGFP was injected unilaterally into the VTA, and whole-brain sections were analyzed for axonal projections. Retrograde tracing was performed by injecting a Cre-dependent retro-AAV and RetroBeads into five candidate target regions (alBNST, CeM, LH, PVT, VP). Electrophysiological recordings of backtraced VTA Sst neurons were conducted using whole-cell current-clamp to classify firing patterns. For behavioral experiments, a Cre-dependent caspase virus (AAV1/2-DIO-taCasp3-TEV) was injected bilaterally into the anterolateral VTA to selectively delete Sst+ neurons (VTA^Sst− mice), with controls receiving GFP-only virus. A comprehensive battery of tests assessed home-cage activity (IntelliCage), anxiety (elevated plus maze, light/dark box, novelty-suppressed feeding), stress responses (forced-swim test, fear conditioning), reward processing (sucrose/saccharine preference, delay discounting, reward learning), and morphine-induced locomotor sensitization. Both male and female mice were used, and statistical analyses included repeated-measures ANOVA with Bonferroni post-hoc tests.
**Key Results:** Anterograde tracing revealed VTA Sst neuron projections to 118 brain regions, with five consistent targets: ventral pallidum (VP), lateral hypothalamus (LH), medial central amygdala (CeM), anterolateral bed nucleus of the stria terminalis (alBNST), and paraventricular thalamic nucleus (PVT). Retrograde tracing confirmed that Sst+ neurons in the anterolateral VTA project to these targets, with PVT receiving bilateral innervation. Electrophysiological recordings showed that 67% of backtraced projection neurons belonged to the afterdepolarizing (ADP) subtype. Behavioral testing of VTA^Sst− mice revealed: (1) increased home-cage nose poking in females (sex × treatment interaction, p=0.014 for adaptation, p=0.010 for habituation); (2) sex-dependent fear conditioning effects—VTA^Sst− males froze less during breaks between footshocks (p=0.036) and VTA^Sst− females froze more (p=0.038), with similar sex × treatment interactions in context-induced fear memory retrieval (p=0.018 for freezing percentage, p=0.022 for freezing episodes); (3) longer latency to immobility in the forced-swim test (p=0.031); (4) enhanced morphine-induced locomotor sensitization (p=0.002) without changes in acute morphine response; and (5) no significant differences in anxiety-like behaviors, sucrose/saccharine preference, delay discounting, or reward learning tasks.
**Clinical Implications:** This study identifies VTA Sst neurons as a novel component of a subcortical Sst+ network involved in stress and addiction-related behaviors. The sex-dependent effects on fear conditioning and home-cage activity highlight the importance of considering sex differences in stress-related psychiatric disorders. The enhanced morphine sensitization in VTA^Sst− mice suggests that these neurons normally limit opioid-induced plasticity, potentially relevant to addiction vulnerability. The findings provide a foundation for future research using optogenetic or chemogenetic approaches to dissect the specific roles of VTA Sst projections in stress and reward circuits, which could inform therapeutic strategies for conditions like post-traumatic stress disorder, anxiety, and substance use disorders.